Hudson Bay Capital Management LP Gossamer Bio, Inc. Transaction History

Hudson Bay Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $794,419 - $1.1 Million	-78,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $957,000 - $1.75 Million	-132,000 Reduced 62.71%	78,500 $987,000
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $284,000 - $346,125	35,500 Added 20.29%	210,500 $1.71 Million
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $37,972 - $48,136	-4,400 Reduced 2.45%	175,000 $1.62 Million
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $585,980 - $959,454	-70,600 Reduced 28.24%	179,400 $1.74 Million
Q3 2020 Nov 12, 2020	SELL	$11.3 - $14.75 $169,500 - $221,250	-15,000 Reduced 5.66%	250,000 $3.1 Million
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $2.52 Million - $4.23 Million	265,000 New	265,000 $3.45 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.